Investors - Press Releases
Tabula Rasa HealthCare Announces Preliminary Second Quarter 2022 Financial Results
- Reports Preliminary Revenue from Continuing Operations of
$72to $73 Millionfor the Second Quarter of 2022, Exceeding Prior Guidance Rangeand Continuing Strong 2022 Performance as Company Focuses on Core Business
- Company Comments on Public Statements by
Indaba Capital Management
Preliminary unaudited revenue from continuing operations for the second quarter of 2022 is expected to be between
Commenting on the preliminary results,
Tunstall continued, "We have an accomplished, diverse, and highly engaged Board with deep, relevant industry experience and business acumen, including nine directors who bring proven expertise across healthcare, finance, public service, and academia. We are confident we have the right Board and management team in place to guide TRHC forward and drive sustainable value for our stockholders as the Company continues to execute on its strategy."
The foregoing forward‐looking statements reflect our expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially.
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give current expectations or forecasts of future events or the Company's future financial or operating performance, and include the Company's expectations regarding healthcare regulations, industry trends, available opportunities to the Company, the financial and operating performance of the Company, the impacts of the COVID-19 pandemic, and the Company's expectations for 2022 and beyond. Such statements are identified by use of the words "believe," "will," "may," "estimate," "expect," "intend," "plans," "predict," "could," or the negative of these terms or similar expressions. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other "forward-looking" information. These statements relate to, without limitation, the Company's financial performance and the assumptions that underlie these statements and the Company's future engagement with stockholders. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. Factors that might cause such a difference include, but are not limited to, (i) the impacts of the ongoing COVID-19 pandemic and other health epidemics; (ii) the Company's ability to adapt to changes or trends within the market for healthcare in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-announces-preliminary-second-quarter-2022-financial-results-301590448.html
Contacts: Media: Anthony Mirenda, email@example.com, 908-380-2143; FGS Global: Andrew Cole/Jared Levy/Warren Rizzi, TRHC-SVC@SARDVERB.com, 212-687-8080; Investors: Frank Sparacino, firstname.lastname@example.org, 866-648-2767